Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Holmberg

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93, Carl-Magnus Rudenstam, David Zahrieh, et al.
Psychoneuroendocrinology|June 29, 2004
Association between the estrogen receptor beta gene and age of onset of Parkinson's diseaseL Westberg, A Håkansson, J Melke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)B C Pestalozzi, D Zahrieh, K N Price, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 17, 2007
Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study GroupLorenzo Gianni, Bernard F Cole, Ilaria Panzini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trialsBernhard C Pestalozzi, David Zahrieh, Elizabeth Mallon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2001
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancerM Colleoni, S Gelber, A S Coates, et al.
European Journal of Cancer (Oxford, England : 1990)|March 17, 2018
A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)H Lindman, M Andersson, J Ahlgren, et al.
Breast Cancer Research and Treatment|October 28, 2008
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93Olivia Pagani, Shari Gelber, Edda Simoncini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancerG Gruber, B F Cole, M Castiglione-Gertsch, et al.
Scandinavian Journal of Urology and Nephrology|November 24, 2005
Safety and efficacy of atorvastatin in patients with severe renal dysfunctionB Holmberg, M Brännström, B Bucht, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93, Carl-Magnus Rudenstam, David Zahrieh, et al.
Psychoneuroendocrinology|June 29, 2004
Association between the estrogen receptor beta gene and age of onset of Parkinson's diseaseL Westberg, A Håkansson, J Melke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)B C Pestalozzi, D Zahrieh, K N Price, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 17, 2007
Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study GroupLorenzo Gianni, Bernard F Cole, Ilaria Panzini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trialsBernhard C Pestalozzi, David Zahrieh, Elizabeth Mallon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2001
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancerM Colleoni, S Gelber, A S Coates, et al.
European Journal of Cancer (Oxford, England : 1990)|March 17, 2018
A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)H Lindman, M Andersson, J Ahlgren, et al.
Breast Cancer Research and Treatment|October 28, 2008
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93Olivia Pagani, Shari Gelber, Edda Simoncini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancerG Gruber, B F Cole, M Castiglione-Gertsch, et al.
Scandinavian Journal of Urology and Nephrology|November 24, 2005
Safety and efficacy of atorvastatin in patients with severe renal dysfunctionB Holmberg, M Brännström, B Bucht, et al.
Pageof 17